Galantamine has been used in recent years to treat Alzheimer’s disease. It is primarily an inhibitor of acetylcholinesterase, which improves clinical symptoms by inhibiting acetylcholinesterase and increasing acetylcholine levels in the patient’s brain, which facilitates improved cognition and memory learning. Other effects of galantamine are also its main uses, including for myasthenia gravis progressive muscular dystrophy, post-polio, childhood cerebral palsy, and neurological disorders resulting in sensory or motor impairment, polyneuritis and other diseases can be treated with galantamine. Galantamine can easily cross the blood-brain barrier, so its central effect is relatively strong and can be used for the treatment of myasthenia gravis. However, galantamine also has certain side effects, so it must be used with more attention. Adverse reactions may cause patients to have bradycardia, dizziness, abdominal pain and other problems.